FDA Guidance Sought To Fill Anticoagulant IVD Gap
This article was originally published in The Gray Sheet
Executive Summary
There is a need for assays to help guide therapy with the growing number of anticoagulant drugs on the market, but without clearer FDA guidelines development will be a challenge, companies and labs tell the agency.